Cargando…

MRI-based radiomics approach for the prediction of recurrence-free survival in triple-negative breast cancer after breast-conserving surgery or mastectomy

To explore the value of a radiomics signature and develop a nomogram combined with a radiomics signature and clinical factors for predicting recurrence-free survival in triple-negative breast cancer patients. We enrolled 151 patients from the cancer imaging archive who underwent preoperative contras...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jingwei, Zhang, Qi, Liu, Muqing, Zhao, Xinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589522/ https://www.ncbi.nlm.nih.gov/pubmed/37861556 http://dx.doi.org/10.1097/MD.0000000000035646

Ejemplares similares

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and meta-analysis
por: Sun, Yixuan, et al.
Publicado: (2017)

MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer
por: Kim, Sungwon, et al.
Publicado: (2020)

Postoperative outcomes of breast reconstruction after mastectomy: A retrospective study
por: Qin, Qinghong, et al.
Publicado: (2018)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastectomy With or Without Radiation
por: Diaz, Dayssy A., et al.
Publicado: (2014)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
por: Saifi, Omran, et al.
Publicado: (2022)

Trends of triple negative breast cancer research (2007–2015): A bibliometric study
por: Wang, Yiran, et al.
Publicado: (2016)

Modified Volumetric Modulated Arc Therapy in Left Sided Breast Cancer After Radical Mastectomy With Flattening Filter Free Versus Flattened Beams
por: Lai, Youqun, et al.
Publicado: (2016)

Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
por: Wang, Xiaosheng, et al.
Publicado: (2016)

Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
por: Di Leone, Alba, et al.
Publicado: (2023)

Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)

Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells
por: Kong, Yan, et al.
Publicado: (2020)

MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1
por: Lee, Soo Jung, et al.
Publicado: (2021)

Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology
por: Chu, Meiling, et al.
Publicado: (2023)

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
por: Ma, Fei, et al.
Publicado: (2017)

Loco-regional outcomes of adjusted breast radiotherapy with conventional fractionation after breast conserving surgery: De-escalation of whole breast irradiation dose
por: Kim, Sang-Won, et al.
Publicado: (2020)

Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
por: Guo, Leqian, et al.
Publicado: (2021)

Breast-Conserving Surgery or Mastectomy?: Impact on Survival
por: Christiansen, Peer, et al.
Publicado: (2022)

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature
por: Ogata, Hideaki, et al.
Publicado: (2015)

Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer
por: Zhu, Jiayu, et al.
Publicado: (2022)

Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in patients of left-sided breast cancer treated with modified radical mastectomy: CONSORT
por: Wang, Rui, et al.
Publicado: (2022)

A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma
por: Wang, Tao, et al.
Publicado: (2021)

Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence
por: Koh, Jieun, et al.
Publicado: (2020)

Triple metachronous primary cancer of uterus, colon, and breast cancer: A case report and review of the literature
por: Li, Guanqiao, et al.
Publicado: (2020)

Assessment of IGF-1 expression in the peripheral blood of women with recurrent breast cancer
por: Costa-Silva, Danylo Rafhael, et al.
Publicado: (2020)

Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report
por: Wu, Hong, et al.
Publicado: (2020)

Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer
por: Sun, Kun, et al.
Publicado: (2023)

Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report
por: Cao, Liyu, et al.
Publicado: (2020)

The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis
por: Tan, Guoqiang, et al.
Publicado: (2018)

Long-term survival and prognostic implications of patients with invasive breast cancer in southern Taiwan
por: Wu, Shih-Chung, et al.
Publicado: (2020)

p-STAT3 expression in breast cancer correlates negatively with tumor size and HER2 status
por: Wang, Yan, et al.
Publicado: (2021)

Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
por: Chen, Chang, et al.
Publicado: (2020)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review
por: Zhao, Xiang-Rong, et al.
Publicado: (2016)

Small-arc volumetric-modulated arc therapy: A new approach that is superior to fixed-field IMRT in optimizing dosimetric and treatment-relevant parameters for patients undergoing whole-breast irradiation following breast-conserving surgery
por: Yu, Jing, et al.
Publicado: (2016)

Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study
por: Liu, Xi-Yu, et al.
Publicado: (2015)

Breast-conserving therapy versus mastectomy
por: van Maaren, Marissa C., et al.
Publicado: (2016)

Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancer
por: Drukker, Karen, et al.
Publicado: (2018)

Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer
por: Ma, Mingming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kl19evh689qg5kn07basu7fe0p